BCRX vs UTHR
BioCryst Pharmaceuticals Inc · United Therapeutics Corporation
Relative return (rebased to 100)
Key stats
| Metric | BCRX | UTHR |
|---|---|---|
| Price | $9.92 | $512.70 |
| Market Cap | $2.53B | $21.99B |
| P/E | 9.61 | 16.48 |
| P/B | — | 3.44 |
| P/S | 2.90 | 6.91 |
| ROE | — | 20.9% |
| Net Margin | 30.2% | 41.9% |
| Gross Margin | — | 87.9% |
| Revenue Growth | 94.1% | 10.6% |
| Dividend Yield | — | — |
| EPS | $1.03 | $31.12 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.